Prescribing Information

 
Please refer to the Prescribing Information for Pritor®/Kinzalmono® as well as PritorPlus®/Kinzalkomb® for details on safety and dosing.

Please note that Prescribing Information is country specific. For information concerning product use in your country please consult your local Prescribing Information.

Quiz

See the latest clinical results and opinions form the International Cardiovascular and Metabolic Academy

www.ICMAedu.com

Link Tip

Learn more about pre-diabetes, a serious condition that needs to be treated:

www.understanding-
prediabetes.com

http://www.pritor.com/scripts/pages/en/professional/management_with_pritor_kinzal/prescribing_information/index.php Copyright © Bayer Schering Pharma AG